Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

Capecitabine and stereotactic radiation in the management of breast cancer brain metastases

Abstract Background Little is known about the safety and efficacy of concurrent capecitabine and stereotactic radiotherapy in the setting of breast cancer brain metastases (BCBM). Methods Twenty-three patients with BCBM underwent 31 stereotactic sessions to 90 lesions from 2005 to 2019 with receipt...

Full description

Bibliographic Details
Main Authors: Matthew N. Mills, Afrin Naz, Chetna Thawani, Chelsea Walker, Nicholas B. Figura, Sergiy Kushchayev, Daniel E. Oliver, Arnold B. Etame, Hsiang-Hsuan Michael Yu, Timothy J. Robinson, James K. C. Liu, Michael A. Vogelbaum, Peter A. Forsyth, Brian J. Czerniecki, Hatem H. Soliman, Hyo S. Han, Kamran A. Ahmed
Format: Article
Language:English
Published: BMC 2021-05-01
Series:BMC Cancer
Subjects:
Capecitabine
Xeloda
Breast cancer
Brain metastases
Stereotactic radiotherapy
Online Access:https://doi.org/10.1186/s12885-021-08302-9

Internet

https://doi.org/10.1186/s12885-021-08302-9

Similar Items